Andreessen Horowitz
San Francisco, CA, United States
Andreessen Horowitz is a venture capital firm based in San Francisco, California. The firm is associated with prominent individuals like Chris Dixon and Davide Ulevitch and collaborates with entities such as Pioneer Fund. They have backed various companies, including TrueMed, and have a network that includes over 360 Y Combinator alumni.
How We Help
Problem Statement
a16z views healthcare as an 'inefficient and costly system,' a 'data, operations, and logistics problem,' and a 'consumer experience and engagement problem' that software and technology can fundamentally improve.
Core Technology
AI in healthcare (specialized AI models for hospitals, clinics, labs), healthtech infrastructure, digital health platforms, medical devices, computational biology, and precision medicine.
Key Differentiators
Platform model providing extensive operational support beyond capital (marketing, talent, legal, policy); stage-agnostic investing (seed to late-stage); investment team often comprises ex-founders and operators; long-term view on relationships; significant investments in AI; partnership with Eli Lilly for 'The Biotech Ecosystem Venture Fund'.
Clinical Focus
Broad spectrum from life sciences to care delivery, including novel therapeutics and diagnostics.
Target Customers
Companies seeking venture capital funding and operational support in the healthcare and biotech sectors, from seed to late-stage.
Company Info
- Business Model
- Venture capital firm that provides capital and extensive operational support (marketing, talent, legal, policy) to companies leveraging software and technology to modernize healthcare's financial layer, improve efficiency, and enhance consumer experience. It is a stage-agnostic investor (seed to late-stage).
- Founded
- 2009
- Total Funding
- 90,000,000,000
- Website
- a16z.com
Categories
Technologies
MedStartr Index Score
?What do you think of Andreessen Horowitz?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.